NASDAQ:ICCM IceCure Medical (ICCM) Stock Price, News & Analysis $1.04 0.00 (0.00%) Closing price 03:59 PM EasternExtended Trading$1.04 +0.00 (+0.38%) As of 05:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About IceCure Medical Stock (NASDAQ:ICCM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IceCure Medical alerts:Sign Up Key Stats Today's Range$1.02▼$1.0750-Day Range$0.92▼$1.1552-Week Range$0.48▼$1.66Volume692,719 shsAverage Volume614,625 shsMarket Capitalization$61.05 millionP/E RatioN/ADividend YieldN/APrice Target$2.50Consensus RatingStrong Buy Company Overview IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel. Read More IceCure Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks51st Percentile Overall ScoreICCM MarketRank™: IceCure Medical scored higher than 51% of companies evaluated by MarketBeat, and ranked 545th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.8 / 5Analyst RatingStrong Buy Consensus RatingIceCure Medical has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageIceCure Medical has only been the subject of 1 research reports in the past 90 days.Read more about IceCure Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for IceCure Medical are expected to grow in the coming year, from ($0.28) to ($0.25) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of IceCure Medical is -3.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of IceCure Medical is -3.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioIceCure Medical has a P/B Ratio of 8.67. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about IceCure Medical's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.84% of the float of IceCure Medical has been sold short.Short Interest Ratio / Days to CoverIceCure Medical has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IceCure Medical has recently increased by 17.61%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIceCure Medical does not currently pay a dividend.Dividend GrowthIceCure Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.84% of the float of IceCure Medical has been sold short.Short Interest Ratio / Days to CoverIceCure Medical has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IceCure Medical has recently increased by 17.61%, indicating that investor sentiment is decreasing significantly. News and Social Media3.0 / 5News Sentiment0.47 News SentimentIceCure Medical has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.04 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for IceCure Medical this week, compared to 2 articles on an average week.Search Interest1 people have searched for ICCM on MarketBeat in the last 30 days. MarketBeat Follows1 people have added IceCure Medical to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, IceCure Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.44% of the stock of IceCure Medical is held by insiders.Percentage Held by InstitutionsOnly 0.62% of the stock of IceCure Medical is held by institutions.Read more about IceCure Medical's insider trading history. Receive ICCM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IceCure Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address ICCM Stock News HeadlinesIceCure Announces Expiration and Results of Approximately Two Times Over-Subscribed Rights Offering for Aggregate Gross Proceeds of $10.0 MillionJuly 29 at 9:00 AM | prnewswire.comIceCure's ProSense® Featured at Japanese Breast Cancer Society Conference: Updated Positive Clinical Data Shows 99% Recurrence Free Rate with CryoablationJuly 25, 2025 | prnewswire.comThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important updates you'll ever see. A new initiative, linked to President Trump's Executive Order #14196, has the potential to do more than just protect Social Security from collapse... According to renowned investor Louis Navellier, it could increase benefits by as much as 400%.July 30 at 2:00 AM | InvestorPlace (Ad)IceCure Reminds Shareholders of Upcoming Expiration of Rights Offering Subscription PeriodJuly 24, 2025 | prnewswire.comIceCure Announces Commencement of Rights OfferingJuly 10, 2025 | prnewswire.comIceCure Medical Ltd (ICCM) - Yahoo FinanceJuly 3, 2025 | finance.yahoo.comIceCure Reports Preliminary Financial Results for the Three and Six Months Ended June 30, 2025July 3, 2025 | prnewswire.comIceCure Medical (NASDAQ:ICCM) shareholders have earned a 51% CAGR over the last five yearsJune 28, 2025 | finance.yahoo.comSee More Headlines ICCM Stock Analysis - Frequently Asked Questions How have ICCM shares performed this year? IceCure Medical's stock was trading at $1.10 at the start of the year. Since then, ICCM stock has decreased by 5.5% and is now trading at $1.04. How were IceCure Medical's earnings last quarter? IceCure Medical Ltd. (NASDAQ:ICCM) issued its quarterly earnings data on Wednesday, May, 28th. The company reported ($0.06) earnings per share for the quarter, topping analysts' consensus estimates of ($0.08) by $0.02. The firm had revenue of $0.73 million for the quarter, compared to analysts' expectations of $0.75 million. IceCure Medical had a negative trailing twelve-month return on equity of 182.26% and a negative net margin of 467.37%. Read the conference call transcript. How do I buy shares of IceCure Medical? Shares of ICCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of IceCure Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that IceCure Medical investors own include Medical Properties Trust (MPW), Realty Income (O), Oxford Square Capital (OXSQ), PayPal (PYPL), A.P. Moller-Maersk (AMKBY), Annaly Capital Management (NLY) and Oxford Lane Capital (OXLC). Company Calendar Last Earnings5/28/2025Today7/30/2025Next Earnings (Estimated)8/19/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Services Sub-IndustryMedical Equipment Current SymbolNASDAQ:ICCM CIK1584371 Webwww.icecure-medical.com Phone972-4623-0333Fax972-4623-0222Employees60Year FoundedN/APrice Target and Rating Average Price Target for IceCure Medical$2.50 High Price Target$2.50 Low Price Target$2.50 Potential Upside/Downside+140.4%Consensus RatingStrong Buy Rating Score (0-4)3.50 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($0.28) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$15.32 million Net Margins-467.37% Pretax Margin-465.45% Return on Equity-182.26% Return on Assets-112.65% Debt Debt-to-Equity Ratio0.02 Current Ratio1.89 Quick Ratio1.48 Sales & Book Value Annual Sales$3.29 million Price / Sales18.56 Cash FlowN/A Price / Cash FlowN/A Book Value$0.12 per share Price / Book8.67Miscellaneous Outstanding Shares58,700,000Free Float57,265,000Market Cap$61.05 million OptionableNot Optionable Beta0.31 Social Links 7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free Report This page (NASDAQ:ICCM) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThe Fed Just Froze You Out (Again)The Fed’s holding rates steady—again. No clarity. No yield. No relief. But one income strategy is quietly t...Investors Alley | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredStrange Investment Secret Predicts Market's Next Move?A strange market signal discovered before the Great Depression has predicted nearly every major financial even...Weiss Ratings | SponsoredThe $1 Trillion Event Tesla Still Hasn’t Recovered FromIn 2010, a “Flash Crash” erased $1 trillion in minutes. Now, one trading legend says it’s happening again—insi...Brownstone Research | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IceCure Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share IceCure Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.